![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/21 | |
A61K 35/17 | |||
A61K 39/00 | |||
A61K 38/20 |
(11) | Number of the document | 1996232 |
(13) | Kind of document | T |
(96) | European patent application number | 07751592.2 |
Date of filing the European patent application | 2007-02-23 | |
(97) | Date of publication of the European application | 2008-12-03 |
(45) | Date of publication and mention of the grant of the patent | 2016-04-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/004841 |
Date | 2007-02-23 |
(87) | Number | WO 2007/103009 |
Date | 2007-09-13 |
(30) | Number | Date | Country code |
778516 P | 2006-03-01 | US |
(72) |
CAI, Zeling, US
MORIARTY, Ann, US
PETERSON, Per, A., US
RICHARDS, Jon, M., US
|
(73) |
Janssen Pharmaceutica N.V.,
Turnhoutseweg 30, 2340 Beerse,
BE
|
(54) | CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES |
CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES |